 When we hit 65 and make it past there, we're going to get it. But now we're, with the help of the Alzheimer's Association research that they support, we're seeing these new drugs, these new treatments. Bacanumab was approved for FDA. Yes. And now, what, yesterday there was another one, Denonumab.